|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocn835671287 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130404s2012 nyu o 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCQ
|d D6H
|d VTS
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9781614705253
|q (electronic bk.)
|
020 |
|
|
|a 1614705259
|q (electronic bk.)
|
029 |
1 |
|
|a DEBBG
|b BV041049522
|
029 |
1 |
|
|a DEBBG
|b BV043775665
|
029 |
1 |
|
|a DEBSZ
|b 472781502
|
035 |
|
|
|a (OCoLC)835671287
|
050 |
|
4 |
|a R850
|b .A38 2012
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 35 /
|c Leon V. Berhardt, editor.
|
260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2012.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Title page of PDF version (Ebsco; viewed on April 4, 2013).
|
505 |
0 |
|
|a ADVANCES IN MEDICINEAND BIOLOGY, VOLUME 35; ADVANCES IN MEDICINE AND BIOLOGY; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Cheese as a Reservoir forAntimicrobial Resistance of Escherichia Coli and Staphylococcus spp.; Abstract; Introduction; Involvement of Food Products inFood-Borne Diseases; Cheese and Dairy Products as a Vehicle forFood-Borne Illnesses; Characteristics and Pathogenecity of E. Coli and Staphylococcus; Escherichia Coli (E. Coli); Enterotoxigenic E. Coli (ETEC); Enteropathogenic E. Coli (EPEC); Enteroinvasive E. Coli (EIEC)
|
505 |
8 |
|
|a Enteroaggregative E. Coli (EAEC)Enterohaemorrhagic E. Coli (EHEC); Staphylococcus spp; E. Coli and Staphylococcus asCauses of Cheese-Borne Infections; Isolation of Bacteria from Cheese; Identification of Bacteria Isolatedfrom Cheese; Escherichia Coli Identification; Staphylococcus Aureus and S. Saprophyticus Identification; Antimicrobial Resistance Mechanisms; Antimicrobial Resistance Testing Method; Antimicrobial Resistance of Staphylococcusand E.coli Isolated from Cheese Samples; Conclusion; References.
|
505 |
8 |
|
|a Multifactorial Approach to the Blood Pressure Control. The Roleof the Asymmetrical Organizationof the Nervous SystemAbstract; 1. Introduction; 2. Brain Asymmetry and Cardiovascular Control; 3. Role of Nitric Oxide in Blood PressureControl. Interaction withthe Renin-Angiotensin System; 4. Role of Dopamine in Blood PressureControl. Interaction withthe Renin-Angiotensin System; 5. New Insights on the Role of the Asymmetrical Organization of the NervousSystem in the Control of Blood Pressure.
|
505 |
8 |
|
|a 5.1. Asymmetrical Responses in Plasma and Blood Pressure afterUnilateral Brain Lesions with 6-Hydroxydopamine6. Concluding Remarks; Acknowledgements; References; Blood-Brain Barrier inHealth and Disease; Abstract; I. The Blood-Brain Barrier; II. Brain Microvascular Endothelial Cells; III. The Blood-Brain Barrier asa Signalling Interface; IV. Intracellular Signalling Pathways inBrain Endothelial Cells; V. Endothelial Interactions inthe Neurovascular Unit; VI. Blood-Brain Barrier Disruptionin Brain Disorders; VII. Conclusion; Acknowledgments; References.
|
505 |
8 |
|
|a Molecular Complexes of Antigen and Adjuvant inVaccine DevelopmentAbstract; 1. Introduction; 2. Molecular Designing of Antigen:Optimization of its Immunogenicity; 2.1. Antigen Complexation with Carrier Molecules; 2.2. Antibody Antigen Complex; 2.3. PAMPs- CpGODN (Cytosieguanosine Oligodeoxynucleotides)Complexed Vaccine; 2.4. Complexation of Antigen with Targeting Ligand; 2.5. Complexation of Antigens with Cytokines; 3. Conclusion and Future Prospective; References; Modelling Factors InfluencingGeneral and Oral HygieneBehaviours in Adolescents; Abstract; Introduction.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Clinical medicine.
|
650 |
|
0 |
|a Biology
|x Research.
|
650 |
|
2 |
|a Clinical Medicine
|
650 |
|
6 |
|a Médecine clinique.
|
650 |
|
6 |
|a Biologie
|x Recherche.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Biology
|x Research
|2 fast
|
650 |
|
7 |
|a Clinical medicine
|2 fast
|
700 |
1 |
|
|a Berhardt, Leon V.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535080
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3020218
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10676349
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 535080
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10251068
|
994 |
|
|
|a 92
|b IZTAP
|